ReviewPharmacological reports : PR2023
Central nervous system disorders after use of dolutegravir: evidence from preclinical and clinical studies.
Alicja Jakimiuk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it